Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We lead colorectal cancer clinical trials, and study the basic biology of non-angiogenic and angiogenic tumours and mechanisms of vascular co-option.

Our group is interested in basic and translational aspects of cancer research, with a particular focus on colorectal cancer. Our group discovered the non-angiogenic pathway of cancer growth, which has led to a change in the hallmarks of cancer. We are therefore investigating the biological basis of these tumours and how the use of anti-angiogenic drugs has changed. For this we are running international trials in colorectal cancer, looking at the interaction between anti-angiogenic drugs and chemotherapy.

Our team

Recent publications

Related research themes